Private Market View

Weixu Biotechnology

Hohhot, China · Founded 2019 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include CUFE Rising Capital.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 1 names
  • ·Watchlist + deal alerts for Weixu Biotechnology
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Weixu Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Weixu Biotechnology

Manufacturer of biotechnology products designed for agricultural and nutritional application purposes. The company integrates biological processing, raw material refinement, and product development functions, enabling agricultural and food markets to improve resource utilization, enhance nutritional value, and strengthen sustainability in production.

Sector
Healthcare
HQ
Hohhot, China
Founded
2019
Employees
4
Ownership
Privately Held (backing)
PA Mark — not yet priced

Weixu Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Weixu Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Weixu Biotechnology in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.